Navigation Links
New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
Date:8/23/2013

And Top Current Challenges Regarding Global & Indian Medical Affairs.
  • Identify What Percentage Of Medical Affairs Budget Leading Companies Allocate To Outsourcing.
  • Trace How Successful Medical Affairs Organizations Work Cross-Functionally To Enhance Effectiveness.
  • This benchmarking research drew participation from 68 Medical Affairs leaders at 50 top pharmaceutical and medical device companies across mature global markets. In addition, the study presents a segment from India-based organizations.

    To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1230.htm.

    For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/.

    ABOUT BEST PRACTICES, LLC

    Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


    '/>"/>
    SOURCE Best Practices, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
    2. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
    3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
    4. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
    5. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    6. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
    7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
    8. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
    9. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
    10. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
    11. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... 2015  The Mesothelioma Victims Center is incredibly ... get the best possible compensation, and they are also ... rare cancer caused by exposure to asbestos or ... to treatment options such as a recent possible ... Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
    (Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
    (Date:5/22/2015)... CITY, Calif. , May 22, 2015 ... pharmaceutical company focused on the development and commercialization of ... pain, today announced that interim chief executive officer ... Healthcare Conference and chief financial officer Tim Morris ... Conference. Details of the two presentations are as follows: ...
    Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
    ... International, Inc. (NYSE: VRX ) (TSX: VRX) today ... live Internet webcast along with a slide presentation on Thursday, ... to discuss results for the 2012 first quarter. ... 876-8393, confirmation code 70937718. International callers should dial (973) ...
    ... April 16, 2012 To mark World Hemophilia Day 2012, ... financial contributions and donations of clotting factor concentrate to the ... program over the period of three years, beginning in 2012. ... minimum shelf-life of one year. The goal of the WFH ...
    Cached Medicine Technology:Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012 2CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period 2CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period 3
    (Date:5/24/2015)... NC (PRWEB) May 24, 2015 Scientists ... a paper on air quality compliance issues that may ... American workers. Surviving Mesothelioma has just posted an article ... now. , The group found airborne asbestos levels ... data collected between 1984 and 2011. , “Asbestos compliance ...
    (Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
    (Date:5/24/2015)... Geneva, WI (PRWEB) May 24, 2015 ... Mercy Health System CEO - ... principal and honored at the fourth ... held April 15 at Geneva National ... (by school): ,     -Badger High School, ...
    (Date:5/23/2015)... D.C. (PRWEB) May 23, 2015 On ... of powers of a youngster's yogic power learned through ... Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, a ... more than 50 high profile professionals attending the 2015 ... by reading fluently -- blindfolded. , In a ...
    (Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
    Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
    ... Md., March 11 Iomai Corporation,(Nasdaq: IOMI ) ... chief executive officer, will present at the Cowen and,Company ... March 17.,Mr. Erck,s presentation will begin at 4:45 p.m. ... at 5:30 p.m., The conference will be held ...
    ... news situation. Some women who have a breast biopsy ... do have atypical hyperplasia -- cells that arent quite ... one-fourth of women undergoing breast biopsies but no one ... quest to discover who is at risk, researchers at ...
    ... The Saada Foundation announced a gift,of $5 million ... Door",capital campaign. This is the largest philanthropic gift received ... $3 million from The Hersh,Foundation and $2.5 million from ... other major donors, the campaign now reaches $14 million ...
    ... that profiles molecular biomarkers in blood could become the first ... The screen relies on changes in dozens of small molecules ... people with Parkinson,s disease, according to a team led by ... City. , They published the findings in the journal Brain. ...
    ... blockers, other meds also increases odds, study finds ... diagnosed and treated for glaucoma and those with high ... for cardiovascular death, a new study suggests. , "Glaucoma ... worldwide," the researchers from Stony Brook University in Stony ...
    ... standard infection control was just as effective ... screening for a common antibiotic-resistant bacteria is no ... rate of hospital-acquired infections in surgical patients, new ... Staphylococcus aureus (MRSA), is an increasing public ...
    Cached Medicine News:Health News:Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 3Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 4Health News:St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift 2Health News:First early-detection blood test for Parkinson's shows promise 2Health News:First early-detection blood test for Parkinson's shows promise 3Health News:Glaucoma May Boost Cardiovascular Death Risk in Blacks 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 3
    Synchron CX3 Delta is a critical care clinical system, providing unparalleled testing speed for the most frequently ordered chemistries-Glucose, BUN, Creatinine, Sodium, Potassium Chloride, CO2 Calci...
    Iron (Total/Ferene). Storage temp: 15 - 30 C. Linearity: 0 - 500 ug/dl. Expected values: from males 60 - 160 ug/dl, from females 43 - 140 ug/dl. Available with Calibrator and Number of test are 120....
    For the quantitative determination of iron, total iron-binding capacity in human serum....
    HDL Cholesterol, liquid....
    Medicine Products: